bicalutamide FDA Link Generic

approved for treatment of advanced prostate cancer

Also Known As:

Casodex; Cosudex; 4'- cyano- 3- (4- fluorophenylsulfonyl)- 2- hydroxy- 2- methyl- 3'- (trifluoromethyl)propionanilide; Astra brand of bicalutamide; AstraZeneca brand of bicalutamide; ICI 176334; ICI-176334; Zeneca brand of bicalutamide; Propanamide, N- (4- cyano- 3- (trifluoromethyl)phenyl)- 3- ((4- fluorophenyl)sulfonyl)- 2- hydroxy- 2- methyl- , (+-)-

Pharmalogical Action Categories:

Androgen Antagonists
Antineoplastic Agents

Organic Chemicals: 58
- Hydrocarbons: 412
  - Cyclic Hydrocarbons: 3
    - Aromatic Hydrocarbons: 132
      - Benzene Derivatives: 13
        Toluene: 648
        Tosyl Compounds
        bicalutamide: 509
- Amides: 231
  - Anilides: 16
    - bicalutamide: 509
- Sulfur Compounds: 135
  - Sulfones: 136
    - Tosyl Compounds
      - bicalutamide: 509
- Nitriles: 34
  - bicalutamide: 509

Create Custom RSS News Feed:
	bicalutamide (Casodex)

Astrazeneca Gmbh Product Research

Products